Ocugen is trading 5.5% up at $1.25 today, rebounding after yesterday’s profit-taking drop and sector-wide weakness.
- The move appears driven by renewed risk-on sentiment as major U.S. indices rally more than 1%.
- Traders are buying back into beaten-down biotech names as broader markets recover from recent pressure.
- There are no new company-specific headlines today to account for the price action.